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Abstract: Doxorubicin (DOXO) is an adjuvant chemotherapy agent and is also commonly used in
cell biology research. Cytotoxic assays in cell culture are frequently used in order to stablish drug
concentrations that are useful for controlling cell proliferation. One common cytotoxic method
used is 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT). Our present research
aims to support future studies in engaging MTT assay using DOXO that exhibits a strong red
coloration and fluorescence, and so it is assumed that DOXO may interfere with commonly used
colorimetric assays such as MTT. The interference of DOXO in the MTT determination was evaluated
in a Breast Cancer cell line Michigan Cancer Foundation-7 (MCF-7). The interference was evaluated
by means of spectroscopic methods in particular spectrophometry and fluorescence spectroscopy
of MTT and DOXO. We postulate that the medium and the MTT reagent itself can interfere on the
metabolic activity method, so in order to achieve better results, DMEM was replaced by a neutral
buffer like Phosphate-buffered saline (PBS). This protocol may be extremely useful in future studies
involving DOXO.
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1. Introduction
Breast cancer (BrCa) is the most common cancer among women and although advances in
screening and treatment have improved, it is still the most invasive form of cancer. Currently, the
first line treatments against BrCa are surgery with radiotherapy, supplemented with chemotherapy.
Doxorubicin (DOXO) is used as an adjuvant therapy component in women with evidence of axillary
lymph node involvement, following resection of primary BrCa [1].
DOXO is the leading compound of a wide family of pharmaceutical anticancer anthracyclines first
discovered from actinobacteria Streptomyces peucetius in the 1960s. It is a DNA intercalator that inhibits
topoisomerase I and II, causing DNA damage and formation of reactive oxygen species (ROS) that
promote caspases activation, and therefore, leads to apoptosis [2]. Frequently used alone, it can also be
administrated in combination with other pharmaceutical agents to treat several types of malignancies
including sarcoma, lymphoma, leukemia and breast cancer.
In order to better understand the mechanisms underlining the analysis of DOXO in cell viability,
we used a breast cancer cell line (MCF-7) that requests Dulbecco’s Modified Eagle Medium (DMEM).
Previous studies demonstrated that the highest interference in absorbance reading of DMEM medium is
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the pH indicator, phenol red [3]. Phenol red color exhibits a gradual transition from yellow (λ = 443 nm)
to red (λ = 570 nm) and can be an interference in colorimetric DOXO assays.
Another potential interference in DOXO is the 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium
Bromide (MTT) reagent which is soluble in culture medium and is cell permeable. MTT measures
metabolic activity since it is mostly based on the cleavage of the tetrazolium ring in active mitochondria,
thus the reaction occurs only in living cells (3). For this reason, it is commonly used to determine
cell proliferation or cytotoxicity of drugs. MTT is reduced to formazan by a variety of intracellular
oxidoreductase enzymes, most notably Nicotinamide adenine dinucleotide (NADH) reductase, and
these formazan crystals can be quantified by absorbance measures within λ = 500 and λ = 600 nm
wavelengths [4]. Thus, formazan absorption spectra overlap with the absorption spectra of
DMEM/phenol red and with DOXO.
Since DOXO, Phenol Red containing medium DMEM and formazan crystals are emitting in visible
light, we hypothesize that they are involved in interference. Therefore, the aim of the present study
was to determine whether DOXO interferes with MTT and pH indicators containing medium.
2. Materials and Methods
2.1. Materials
2.1.1. Chemicals
Phosphate Buffered Saline, or PBS (Amresco, Solon, OH, USA), Doxorubicin hydrochloride
(DOXO, Sigma Aldrich, St. Louis, MO, USA). Aqueous stock solutions of DOXO was prepared using
18.2 MΩ ultrapure water obtained from a Milli-Q Plus Millipore water filtration system; Dulbecco’s
Modified Eagle Medium (DMEM) (Sigma, St. Louis, MO, USA); Fetal Bovine Serum (FBS) (Invitrogen
Life technologies, Carlsbad, CA, USA); penicillin/streptomycin (Invitrogen Life technologies, Carlsbad,
CA, USA); Sodium bicarbonate (Merck, Darmstadt, Germany); Dimethyl Sulfoxide (DMSO, Merck,
Darmstadt, Germany), MTT reagent (Abcam, Cambridge, UK).
2.1.2. Cells
Human breast carcinoma cells (MCF-7) was obtained from Professor Raquel Soares (Biomedicine
department, Faculty of Medicine, University of Porto, Porto, Portugal).
2.1.3. Equipment
UV−Vis spectrophotometer (Evolution 220); Fluorescence spectrophotometer (F-4500); Humidified
atmosphere chamber; Inverted microscope, Neubauer Chamber Cell Counting.
2.2. Methods
2.2.1. Absorbance Spectra
An absorbance scanning was performed using a UV-VIS spectrophotometer from 450 to 650 nm
wavelength of MTT, formazan, DMEM, MTT, DMEM+MTT at the final concentration used in the assay.
2.2.2. Intrinsic Emission Fluorescence by Fluorescence Spectrometry
The fluorescence spectra of DOXO standard were analyzed using a fluorescence spectrophotometer.
Spectra were recorded on a 1 cm path-length cuvette with an excitation slit width of 20 nm and an
emission slit width of 20 nm. The excitation wavelength was set at 480 nm and the emission spectra
were recorded starting at 500 nm, ending on 700 nm.
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2.2.3. Dose-Response Curve Based on MTT
Human breast carcinoma cells (MCF-7) were cultured in DMEM, supplemented with 10% FBS,
1% penicillin/streptomycin and 3.7 g/L sodium bicarbonate and maintained at 37 ◦C in a humidified
atmosphere containing 5% CO2. The cells were used between passages 17 to 29.
MCF-7 cells were seeded in a 96-well plate at a density of 1 × 105 cells/mL and incubate in
complete medium at 37 ◦C. Treatment was administered after 24 h. DOXO was formulated in serum
free medium in concentrations of 0.05, 0.1, 0.2, 0.4, 0.8, 1, 1.6 and 3 µg/mL, and 3 replicates were used
for each concentration, with a final volume of 200 µL. Following 24 h of treatment incubation, the
medium was removed and changed to PBS, 20 µL of 20 mM of MTT (dissolved in PBS) was added
and incubated for 3 h at 37 ◦C. After incubation, the solution was carefully removed and 200 µL
DMSO was added in order to solubilize the violet formazan crystals. The plates were then shaken on a
horizontal shaker for 5 min to allow for complete dissolution. The optical density (OD) was read using
Multiskan Ascent spectrophotometer (ThermoFischer, Waltham, MA, USA) at a dual wavelength of
λ = 550/650 nm. Analyses were performed in triplicate.
3. Results
3.1. Absorbance Spectra
When comparing the absorbance of DOXO, MTT, Formazan, DMEM and DMEM+MTT it is
possible to observe that there is a superposition between DOXO, Formazan, DMEM and DMEM+MTT
(Figure 1) that can directly interfere in colorimetric methods. Moreover, the fluorescence spectrum
of DOXO characteristically presents two main peaks when dissolved in water (at λ = 560 nm and at
λ = 593 nm), the first peak is also overlaid with the other compounds.
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Figure 1. Comparison of the absorbance spectra of all intervenient compounds in MTT assay.
Absorbance scanning between 450 and 650 nm wavelength where it is possible to see the overlapping
of DMEM, Formazan and DMEM+MTT at 560 nm (a). The fluorescence spectra of DOXO standard
with excitation wavelength set to 480 nm and emission spectra recorded starting in 500 nm, ending on
700 nm, once again, a peak at 560 nm coincident to the measurements of formazan, DMEM and MTT. It
is also possible to observe a correlation between concentration and fluorescence intensity (b).
3.2. Dose-Response Curve Based on MTT
Using a protocol of MTT accordingly to the manufacturer’s instructions with 12 h (Figure 2a)
and 24 h (Figure 2b) incubation periods with different DOXO concentrations on the MCF-7 cell line,
with MTT reagent added directly to the medium, a tendency to increase the metabolic activity was
observed, which contradicted the expected cytotoxic action of this drug.
In order to address this issue, DMEM was changed to PBS and then MTT assay was conducted
according to the manufacturer’s instructions. Changing DMEM to PBS, nonsense plots disappear, and
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the result plot is an expected dose-response curve where the metabolic activity of cancer cells decreases
in a constant manner (Figure 2c).
Methods Protoc. 2019, 2, 29 4 of 5 
 
 
Figure 2. (a) and (b) Representations of metabolic activity by MTT incubated with DMEM medium at 
12 and 24 h, respectively, in different DOXO concentrations. In both cases, results are not acceptable 
for high DOXO concentrations that reveal high viability rates (c) Representation of cytotoxicity of 
different concentrations of DOXO after wash and incubation of MTT reagent with PBS. With our 
protocol, the results become acceptable because they described an expected dose-response curve. 
4. Discussion and Conclusions 
Analyzing the spectra of the reagents of MTT protocol individually, absorbance of MTT itself 
does not overlap the absorbance spectrum neither with DOXO nor formazan. However, both DMEM 
and the mixture DMEM-MTT have their highest absorbance at the same wavelength as DOXO and 
formazan crystals (Figure 1). This must to be taken into consideration when using other colorimetric 
methods involving cell culture and DOXO in the sense that such overlap will interfere with each 
other. Regarding DOXO spectra it also interferes with MTT, probably due to the incubation time in 
the DMEM/MTT period. When MTT is incubated in PBS, this interference disappears since DMEM 
was wash out of the reading plate well.  
Analysis of all spectra was crucial for the understanding that, although DMSO is considered the 
best solvent for dissolving formazan crystals [5], residual medium/treatments can still be found in 
the microtiter wells and can indeed change the shape of the absorbance spectra. 
MTT is still amongst the most common methods used to determine proliferation, viability, 
toxicity and metabolic activity, although an emerging understanding indicates many limitations of 
this method regarding complexity, sensitivity and retrieval [6]. We recognized that another limitation 
must be taken in account: reactions with the colorimetric nature of the compounds in study in each 
particular experimental setup.  
Taking DOXO as an example, every single colored compound whose effect on cells is under the 
assessment of a cytotoxicity assay using dyes such as formazan might interfere with each other. 
DOXO spectra overlaps with formazan absorption. This interference will result in misleading readings.  
Altogether, these findings indicate that the classical approach of MTT quantification using 
DOXO directly interferes in the metabolic activity measurement. Removing treatment media from 
the cell culture and exchanging to PBS results provides viable and clear results such as those 
demonstrated in a dose-response curve determination (Figure 2).  
Figure 2. (a) and (b) Representations of metabolic activity by MT incubated with DMEM medium at
12 and 24 h, respectively, in different DOX con e trations. I both cases, r ults are not acceptable for
high DOXO concentratio s that reve l high viability r tes (c) Representation of cy otoxicity of different
concentra ions of DOXO after wash and incubatio of MTT reagent with PBS. With our protocol, the
results become acceptable because they described an exp cted dose-res onse curve.
4. Discussion and Conclusions
Analyzing the spectra of the reagents of MTT protocol individually, absorbance of MTT itself
does not overlap the absorbance spectrum neither with DOXO nor formazan. However, both DMEM
and the mixture DMEM-MTT have their highest absorbance at the same wavelength as DOXO and
formazan crystals (Figure 1). This must to be taken into consideration when using other colorimetric
methods involving cell culture and DOXO in the sense that such overlap will interfere with each
other. Regarding DOXO spectra it also interferes with MTT, probably due to the incubation time in the
DMEM/MTT period. When MTT is incubated in PBS, this interference disappears since DMEM was
wash out of the reading plate well.
Analysis of all spectra was crucial for the understanding that, although DMSO is considered the
best solvent for dissolving formazan crystals [5], residual medium/treatments can still be found in the
microtiter wells and can indeed change the shape of the absorbance spectra.
MTT is still amongst the most common methods used to determine proliferation, viability, toxicity
and metabolic activity, although an emerging understanding indicates many limitations of this method
regarding complexity, sensitivity and retrieval [6]. We recognized that another limitation must be
taken in account: reactions with the colorimetric nature of the compounds in study in each particular
experimental setup.
Taking DOXO as an example, every single colored compound whose effect on cells is under the
assessment of a cytotoxicity assay using dyes such as formazan might interfere with each other. DOXO
spectra overlaps with formazan absorption. This interference will result in misleading readings.
Methods Protoc. 2019, 2, 29 5 of 5
Altogether, these findings indicate that the classical approach of MTT quantification using DOXO
directly interferes in the metabolic activity measurement. Removing treatment media from the cell
culture and exchanging to PBS results provides viable and clear results such as those demonstrated in
a dose-response curve determination (Figure 2).
We consider that the present work may contribute to the design of several in vitro cell culture
experiments using colorimetric assays.
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